SK126799A3 - Isoquinolyl-benzamide derivatives, process for their production, pharmaceutical composition containing them and their use - Google Patents

Isoquinolyl-benzamide derivatives, process for their production, pharmaceutical composition containing them and their use Download PDF

Info

Publication number
SK126799A3
SK126799A3 SK1267-99A SK126799A SK126799A3 SK 126799 A3 SK126799 A3 SK 126799A3 SK 126799 A SK126799 A SK 126799A SK 126799 A3 SK126799 A3 SK 126799A3
Authority
SK
Slovakia
Prior art keywords
alkyl
hydrogen
cycloalkyl
alkylco
disorders
Prior art date
Application number
SK1267-99A
Other languages
English (en)
Slovak (sk)
Inventor
John David Harling
Barry Sidney Orlek
Mervyn Thompson
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9705620.4A external-priority patent/GB9705620D0/en
Priority claimed from GBGB9726660.5A external-priority patent/GB9726660D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK126799A3 publication Critical patent/SK126799A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK1267-99A 1997-03-18 1998-03-16 Isoquinolyl-benzamide derivatives, process for their production, pharmaceutical composition containing them and their use SK126799A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9705620.4A GB9705620D0 (en) 1997-03-18 1997-03-18 Novel compounds
GBGB9726660.5A GB9726660D0 (en) 1997-12-17 1997-12-17 Novel compounds
PCT/GB1998/000781 WO1998041507A1 (en) 1997-03-18 1998-03-16 Anti-convulsant isoquinolyl-benzamide derivatives

Publications (1)

Publication Number Publication Date
SK126799A3 true SK126799A3 (en) 2000-05-16

Family

ID=26311216

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1267-99A SK126799A3 (en) 1997-03-18 1998-03-16 Isoquinolyl-benzamide derivatives, process for their production, pharmaceutical composition containing them and their use

Country Status (26)

Country Link
US (1) US6277861B1 (ru)
EP (1) EP0971897A1 (ru)
JP (1) JP2001516357A (ru)
KR (1) KR20000076343A (ru)
CN (1) CN1255917A (ru)
AP (1) AP9901635A0 (ru)
AR (1) AR012078A1 (ru)
AU (1) AU732162B2 (ru)
BG (1) BG103807A (ru)
BR (1) BR9809048A (ru)
CA (1) CA2283682A1 (ru)
CO (1) CO4950554A1 (ru)
DZ (1) DZ2446A1 (ru)
EA (1) EA199900836A1 (ru)
ID (1) ID22730A (ru)
IL (1) IL131958A0 (ru)
MA (1) MA24499A1 (ru)
NO (1) NO313753B1 (ru)
NZ (1) NZ337579A (ru)
OA (1) OA11390A (ru)
PE (1) PE62199A1 (ru)
PL (1) PL335675A1 (ru)
SK (1) SK126799A3 (ru)
TR (1) TR199902282T2 (ru)
TW (1) TW509679B (ru)
WO (1) WO1998041507A1 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001518468A (ja) * 1997-09-30 2001-10-16 モレキュラー デザインズ インターナショナル,インコーポレイテッド β3アドレナリン受容体拮抗薬、拮抗薬合成物およびこれらの応用方法
GB9817424D0 (en) 1998-08-11 1998-10-07 Smithkline Beecham Plc Novel compounds
GB9915589D0 (en) * 1999-07-02 1999-09-01 Smithkline Beecham Plc Novel compounds
US6593341B2 (en) 2001-03-29 2003-07-15 Molecular Design International, Inc. β3-adrenoreceptor agonists, agonist compositions and methods of making and using the same
US6596734B1 (en) 2002-10-11 2003-07-22 Molecular Design International, Inc. Tetrahydroisoquinoline compounds for use as β3-adrenoreceptor agonists
CN109608325A (zh) * 2018-12-27 2019-04-12 先尼科化工(上海)有限公司 一种卤代苯甲酸衍生物的工业化合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022900A (en) * 1970-09-09 1977-05-10 Marion Laboratories, Inc. Compositions containing 1,2,3,4-tetrahydroisoquinolines used as hypotensive agents
JPH01503233A (ja) * 1986-10-28 1989-11-02 スミス・クライン・アンド・フレンチ・ラボラトリース・リミテッド 製薬活性化合物
GB8807922D0 (en) * 1988-04-05 1988-05-05 Fujisawa Pharmaceutical Co Isoquinoline compound & process for preparation thereof
US4883593A (en) * 1988-10-27 1989-11-28 Bend Research, Inc. Ultrathin-skinned asymmetric membranes by immiscible solvents treatment
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
CZ416498A3 (cs) * 1996-06-17 1999-06-16 Smithkline Beecham Plc Substituovaný benzamidový derivát a jeho použití jako antikonvulsantu

Also Published As

Publication number Publication date
OA11390A (en) 2004-04-14
PE62199A1 (es) 1999-09-10
WO1998041507A1 (en) 1998-09-24
NO313753B1 (no) 2002-11-25
AP9901635A0 (en) 1999-09-30
DZ2446A1 (fr) 2003-01-11
TW509679B (en) 2002-11-11
BR9809048A (pt) 2000-08-01
JP2001516357A (ja) 2001-09-25
US6277861B1 (en) 2001-08-21
AU732162B2 (en) 2001-04-12
EP0971897A1 (en) 2000-01-19
CO4950554A1 (es) 2000-09-01
KR20000076343A (ko) 2000-12-26
BG103807A (bg) 2001-05-31
NO994504L (no) 1999-09-17
PL335675A1 (en) 2000-05-08
CN1255917A (zh) 2000-06-07
MA24499A1 (fr) 1998-10-01
AR012078A1 (es) 2000-09-27
TR199902282T2 (en) 2000-07-21
IL131958A0 (en) 2001-03-19
AU6412798A (en) 1998-10-12
ID22730A (id) 1999-12-09
NZ337579A (en) 2001-04-27
NO994504D0 (no) 1999-09-17
CA2283682A1 (en) 1998-09-24
EA199900836A1 (ru) 2000-04-24

Similar Documents

Publication Publication Date Title
KR100568654B1 (ko) 치환된 이소퀴놀린 유도체 및 진경제로서의 그의 용도
CZ416498A3 (cs) Substituovaný benzamidový derivát a jeho použití jako antikonvulsantu
SK9142000A3 (en) Tetrahydro isoquinolinyl carboxamide compounds, preparation thereof, pharmaceutical composition containing them and their use
SK126799A3 (en) Isoquinolyl-benzamide derivatives, process for their production, pharmaceutical composition containing them and their use
JP2007145862A (ja) 置換イソキノリン誘導体および抗痙攣剤としてのその使用
SK18962000A3 (sk) Tetrahydronaftyridinylkarboxamidové zlúčeniny, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie
KR20010072262A (ko) 삼환식 카르복스아미드
US6492378B1 (en) Substituted isoquinoline derivatives and their use as anticonvulsivants
CZ326299A3 (cs) Antikonvulsivní isochinolylbenzamidové deriváty
MXPA99008627A (en) Anti-convulsant isoquinolyl-benzamide derivatives
CZ20002221A3 (cs) Substituované deriváty isochinolinu a jejich použití jako antikonvulziva
WO2000008022A1 (en) Urea derivatives
JP2001508402A (ja) 置換ベンズアミド誘導体およびそれらの抗痙攣薬としての使用
KR20000016715A (ko) 치환된 벤즈아미드 유도체 및 항경련제로서의그의 용도ㅔ
MXPA99008583A (en) Substituted isoquinoline derivatives and their use as anticonvulsants